Genmab — Oktober 2018
-
New Trial in Singapore:
Daratumumab in Combination With Bortezomib and Dexamethasone in Newly Diagnosed Transplant Ineligible Multiple Myeloma https://clinicaltrials.gov/ct2/show/NCT03695744?term=NCT03695744&rank=1 -
Uhyggeligt spændende hvor vi ender inden det vender..
-
På et tidspunkt...ja
-
Håber ikke vi skal vente til den 16..
-
Som Hamlet.." there is something rotten in the state of
Denmark" -
Vi kommer nok til at teste 970 inden forhåbentlig gode salgstal d. 16
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind